It is upregulated in breast cancer and enhances tumor growth and progression by silencing the protein tyrosine phosphatase, PTPN9 [161] and the tumor suppressor genes FOXO1 [162] and FOXO3a [163]. The gene discussed is FOXO1; the disease is neoplasm.